Abingdon Health Management

Management criteria checks 2/4

Abingdon Health's CEO is Chris Henry Yates, appointed in Jul 2015, has a tenure of 9.42 years. total yearly compensation is £323.00K, comprised of 82.7% salary and 17.3% bonuses, including company stock and options. directly owns 2.05% of the company’s shares, worth £611.39K. The average tenure of the management team and the board of directors is 1.8 years and 12.8 years respectively.

Key information

Chris Henry Yates

Chief executive officer

UK£323.0k

Total compensation

CEO salary percentage82.7%
CEO tenure9.4yrs
CEO ownership2.0%
Management average tenure1.8yrs
Board average tenure12.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Chris Henry Yates's remuneration changed compared to Abingdon Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024UK£323kUK£267k

-UK£1m

Mar 31 2024n/an/a

-UK£2m

Dec 31 2023n/an/a

-UK£2m

Sep 30 2023n/an/a

-UK£3m

Jun 30 2023UK£278kUK£225k

-UK£3m

Mar 31 2023n/an/a

-UK£11m

Dec 31 2022n/an/a

-UK£18m

Sep 30 2022n/an/a

-UK£20m

Jun 30 2022UK£222kUK£203k

-UK£21m

Mar 31 2022n/an/a

-UK£17m

Dec 31 2021n/an/a

-UK£12m

Sep 30 2021n/an/a

-UK£10m

Jun 30 2021UK£455kUK£251k

-UK£7m

Mar 31 2021n/an/a

-UK£5m

Dec 31 2020n/an/a

-UK£3m

Sep 30 2020n/an/a

-UK£3m

Jun 30 2020UK£228kUK£213k

-UK£3m

Compensation vs Market: Chris Henry's total compensation ($USD404.66K) is about average for companies of similar size in the UK market ($USD349.06K).

Compensation vs Earnings: Chris Henry's compensation has increased whilst the company is unprofitable.


CEO

Chris Henry Yates (50 yo)

9.4yrs

Tenure

UK£323,000

Compensation

Mr. Chris Henry Francis Yates has been Independent Non-Executive Director of genedrive plc since August 22, 2018. He Co-Founded diagnostics group Abingdon Health (“Abingdon”) in 2008 and he has been the Ch...


Leadership Team

NamePositionTenureCompensationOwnership
Christopher Hand
Executive Chairman16.9yrsUK£89.00k3.42%
£ 1.0m
Chris Henry Yates
CEO, Company Secretary & Director9.4yrsUK£323.00k2.05%
£ 611.4k
Laura Towse
Group Financial Controllerless than a yearno datano data
Mark Jones
Chief Operating Officer2.8yrsno datano data

1.8yrs

Average Tenure

Experienced Management: ABDX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Christopher Hand
Executive Chairman16.9yrsUK£89.00k3.42%
£ 1.0m
Chris Henry Yates
CEO, Company Secretary & Director12.8yrsUK£323.00k2.05%
£ 611.4k
Mary Tavener
Senior Independent Non-Executive Director4.2yrsUK£41.00kno data
Dene Baldwin
Member of Medical & Scientific Advisory Boardno datano datano data
Lawrence Young
Member of Medical & Scientific Advisory Boardno datano datano data
Tara Moore
Member of Medical & Scientific Advisory Boardno datano datano data
Mike Holmes
Member of Medical & Scientific Advisory Boardno datano datano data

12.8yrs

Average Tenure

62yo

Average Age

Experienced Board: ABDX's board of directors are seasoned and experienced ( 12.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 05:16
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abingdon Health Plc is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emma UlkerWH Ireland Limited
Emma UlkerZeus Capital Limited